Vimarsana
Biggest News Aggregation in the World

Page 13 - Ar T News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ar T. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ar T Today - Breaking & Trending Today

Strategies Evolve for B-Cell Depletion in Lupus Nephritis - Vimarsana News

Strategies Evolve for B-Cell Depletion in Lupus Nephritis

Growing evidence suggests more complete B-cell depletion in patients with lupus nephritis is associated with a greater likelihood of treatment response.

'Remarkable': CAR T Therapy for CLL/SLL - Vimarsana News

'Remarkable': CAR T Therapy for CLL/SLL

CAR T-cell therapy showed efficacy in achieving complete responses among patients with relapsed or refractory CLL or SLL after BTKi and BCL2 inhibitor.

Cellectis Presents Updated Clinical and Translational Data - Vimarsana News

Cellectis Presents Updated Clinical and Translational Data

NEW YORK, June 09, 2023 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company...

Global and China Passenger Car T-Box Market 2023: T-Box has - Vimarsana News

Global and China Passenger Car T-Box Market 2023: T-Box has

Dublin, June 06, 2023 (GLOBE NEWSWIRE) -- The "Global and China Passenger Car T-Box Market Report, 2023" report has been added to ...

CAR T-Cell Benefit in Lenalidomide-Refractory Myeloma - Vimarsana News

CAR T-Cell Benefit in Lenalidomide-Refractory Myeloma

The CAR T-cell construct was associated with significantly better progression-free survival than standard-of-care multidrug regimens.